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Abstract 26 
 27 
Objectives– To detect and localise bacteria in gallbladder mucoceles utilizing fluorescence in 28 
situ hybridization (FISH). To report clinical signs, clinicopathologic abnormalities, sonographic 29 
findings and histopathological findings in FISH+ and FISH- dogs with gallbladder mucoceles.  30 
Materials and Methods – Retrospective review of signalment, clinical signs, clinicopathologic 31 
and sonographic findings of 25 cases of histopathologically confirmed gallbladder mucocele. 32 
Histopathological sections of GBM were evaluated for cystic mucinous hyperplasia, cystic 33 
mucinous hyperplasia with cholecystitis and rupture. The number and spatial distribution of 34 
bacteria was determined by eubacterial FISH. Gallbladder contents were cultured in 21 dogs.  35 
Results –Bacteria were detected within or adherent to the gallbladder in eight of 25 (32%) cases 36 
Bacterial culture was positive in one dog. Cystic mucinous hyperplasia with concurrent 37 
cholecystitis was found in 17/25 (68%) of dogs with gallbladder mucocele.   38 
Clinical significance – FISH was more sensitive for detection of bacteria in gallbladder 39 
mucoceles when compared to bacterial culture of bile. Cholecystitis was common in dogs with 40 
gallbladder mucocele. Further study is required to elucidate the relationship of cystic mucinous 41 
hyperplasia, bacteria and cholecystitis in the aetiopathogenesis and progression of GBM.  42 
 43 
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Gallbladder mucocele (GBM) has emerged as a common and clinically important cause of 47 
extrahepatic biliary disease in the dog. GBM is most frequently reported in older dogs and 48 
 3 
predisposed breeds include the Shetland sheepdog, Pomeranian, miniature schnauzer, cocker 49 
spaniel, Chihuahua, and Border terrier (Worley et al. 2004, Aguirre et al. 2007, Crews et al. 50 
2009, Malek et al. 2013, Gookin et al. 2015, Mitzutani et al. 2017, Allerton et al. 2018). GBM is 51 
characterized by cystic mucinous hyperplasia (CMH) and the accumulation of viscous bile and 52 
mucus in the GB (Neer 1992, Besso et al. 2000, Pike et al. 2004, Worley et al. 2004, Aguirre et 53 
al. 2007, Malek et al. 2013). The underlying cause of GBM formation is not well understood 54 
(Neer 1992, Besso et al. 2000, Pike et al. 2004) but may involve the excess secretion of 55 
particular gel-forming mucins (Kesimer et al. 2015) and dysmotility (Tsukagoshi et al. 2012).  56 
 57 
Bacterial culture has been reported positive in 3-67% of cases of GBM (Pike et al. 2004, Worley 58 
et al. 2004, Aguirre et al. 2007, Mayhew et al. 2008, Crews et al. 2009, Malek et al. 2013, 59 
Policelli et al. 2017, Mitzutani et al. 2017, Policelli Smith et al. 2017). This wide variation may 60 
reflect the use of perioperative antimicrobial therapy, and differences in sampling and culture 61 
based methodologies. The prevalence of bacterial infection in GBM could also be impacted by 62 
concurrent comorbidities such as cholecystitis or cholelithiasis, conditions which have reported 63 
culture positive rates of 35-50%  (Mehler et al. 2004, Aguirre et al. 2007). Concurrent 64 
cholecystitis has been reported in 17-40% of dogs with GBM (Besso et al. 2000, Pike et al. 65 
2004, Worley et al. 2004, Malek et al. 2013). 66 
 67 
Co-morbidities such as bacterial infection and cholecystitis could impact the progression and 68 
outcome of GBM. For example, septic bile peritonitis is significantly associated with mortality in 69 
dogs receiving extrahepatic biliary tract surgery for a variety of causes including cholelithiasis, 70 
cholecystitis, neoplasia, and trauma (Mehler et al. 2004). Mural inflammation, erosion and 71 
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ulceration of the GB could compromise the structural integrity of the GB and predispose to 72 
rupture. Timely recognition of bacterial infection and cholecystitis could influence the medical 73 
management of GBM and reduce perioperative mortality. Further, because cholecystectomy may 74 
be postponed in cases of suspected benign GBM, there is a clear need to better understand the 75 
relationship of concurrent bacterial infection and cholecystitis to GBM.  76 
 77 
Fluorescent in-situ hybridization (FISH) is a culture-independent technique that enables 78 
visualization and localisation of intact bacteria in formalin-fixed, paraffin wax-embedded tissues. 79 
FISH has been used to document bacteria in a variety of cells and tissues and in some cases has 80 
been demonstrated to be more sensitive for detection of bacteria when compared to culture 81 
(Simpson et al. 2006, Recordati et al. 2009, Warren et al. 2011, Kornreich et al. 2012, Twedt et 82 
al. 2014). To our knowledge, FISH has not been used previously to detect bacteria in archived 83 
GB samples in dogs. 84 
 85 
The objectives of this study were to 1) detect, count and localise bacteria in GBMs when 86 
evaluated by FISH and 2) report clinical signs, clinicopathologic abnormalities, sonographic 87 
findings and histopathological findings in FISH+ and FISH- dogs with GBM.  88 
 89 
 90 
Materials and Methods  91 
Inclusion Criteria and Case Data Review  92 
Electronic medical records (EMR) at Colorado State University were reviewed for cases of 93 
histopathologically confirmed canine GBM between December 2010 and January 2015. Dogs 94 
were included if their primary diagnosis was gallbladder mucocele with no significant concurrent 95 
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extra-hepatobiliary disease noted in the EMR, and a complete blood count, biochemical profile 96 
and abdominal ultrasound had been performed within 48 hours prior to cholecystectomy. 97 
Retrospective case review included signalment, clinical signs, clinicopathological abnormalities, 98 
peri-operative outcome, and bacterial culture of bile and antimicrobial use. 99 
 100 
FISH 101 
Formalin-fixed paraffin-embedded histological sections (4 μm) were mounted on Probe-On Plus 102 
slides (Fisher Scientific) and evaluated by FISH as previously described (Simpson et al. 2006). 103 
In short, paraffin-embedded biopsy specimens were de-paraffinized by passage through xylene 104 
(3 × 10 mins), 100% alcohol (2 × 5 mins), 95% ethanol (5 mins) and, finally, 70% ethanol (5 105 
mins). The slides were air-dried. FISH probes 5’-labeled with either Cy3 or 6-FAM (Integrated 106 
DNA Technologies) were reconstituted with sterile water and diluted to a working concentration 107 
of 5 ng/µl with a hybridization buffer appropriate to the probe. For evaluation EUB338 Cy-3 was 108 
combined with the irrelevant probe non-EUB- 338-FAM (ACTCCTACGGGAGGCAGC) to 109 
control for non-specific hybridization. Sections were examined on an Olympus BX51 110 
epifluorescence microscope and images captured with an Olympus DP-7 camera (Olympus 111 
America). The relative number and spatial orientation of bacteria within the section of 112 
gallbladder was also recorded.  113 
 114 
Ultrasonographic Data 115 
All ultrasound examinations were performed by a board-certified veterinary radiologist or a 116 
veterinary radiology resident under the direct supervision of a board-certified veterinary 117 
radiologist.  Written reports, still images, and video clips of ultrasonographic examinations were 118 
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then retrospectively reviewed by a board-certified veterinary radiologist (EKR) blinded to the 119 
case data. The appearance of the gallbladder, gallbladder wall, adjacent abdominal structures, 120 
and free peritoneal fluid was evaluated. Sonographic features of GBM were defined as stellate or 121 
finely striated bile patterns that differed from biliary sludge by the absence of gravity-dependent 122 
bile movement (Besso et al. 2000).  The gall bladder wall was evaluated for echogenicity, 123 
presence of oedema, thickening and rupture. A thickened gallbladder wall was defined as more 124 
than 2 mm in dogs (Nyland & Hager 1985). GB wall oedema was defined as a thickened GB wall 125 
with a hypoechoic layer within the GB wall.  126 
 127 
Histopathological Evaluation  128 
Original histopathologic reports (all by board-certified veterinary pathologists) were reviewed to 129 
confirm a diagnosis of GBM. Following this, archival formalin-fixed paraffin-embedded tissue 130 
blocks were located for 23/25 cases, sectioned at 4 um and stained with hematoxylin and eosin 131 
(HE) for blinded review by a board-certified veterinary pathologist (SLP) employing WSAVA 132 
criteria for CMH and cholecystitis (Rothuizen 2006). Cholecystitis was defined as the presence 133 
of a neutrophilic and/or lymphoplasmacytic infiltrate in the epithelium or wall of the gallbladder 134 
+/- fibrosis (Rothuizen 2006) and assigned a grade of mild, moderate or severe.  Each case was 135 
assigned to one of 4 groups: CMH, CMH with cholecystitis (CMHC), mild, moderate or severe.  136 
 137 
Statistical Analysis  138 
Descriptive statistics were calculated for the presence/absence of clinical signs, 139 
clinicopathological data, sonographic findings, and histologic findings  in FISH+ versus FISH- 140 
dogs with GBM.  141 
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Results 142 
    143 
Twenty-six dogs with a histopathological diagnosis of gallbladder mucocele were identified. One 144 
dog was excluded due to concurrent hemolytic anemia and so 25 cases were included. Tissue 145 
blocks for 23 of 25 cases were available for blinded histopathological review.  146 
 147 
Patient Demographics, Clinical and Clinicopathologic Characteristics and Outcome 148 
The median age was 11 (n=25; range, 6-14), with a near even distribution between castrated 149 
male 12 (48%) and spayed females 13 (52%). Breeds included mixed (n=10), Shetland sheepdog 150 
(n=3), miniature schnauzer (n=2), Pomeranian (n=2), and one each of the following: Australian 151 
shepherd, Bernese mountain dog, cocker spaniel, Labrador retriever, Maltese, miniature 152 
dachshund, miniature poodle and Yorkshire Terrier. Due to the retrospective nature of this study 153 
it was not possible to fully determine the presence or absence of potential medical conditions 154 
predisposing to mucocele in every case (Mesich et al. 2009, Kutsani et al. 2014, Gookin et al. 155 
2015). Three mixed breed dogs had a previous diagnosis of hyperadrenocorticism.  156 
 157 
Clinical signs were present in 18 of 25 (72%) dogs with GBM (Table 1). Change in appetite (i.e. 158 
hyporexia or anorexia) was most common, 12/25 (48%). Other clinical signs included: vomiting 159 
(11/25;44%), lethargy (9/25;36%), diarrhea (6/25;24%), abdominal pain (4/25;16%), jaundice 160 
(3/25;12%), polyuria/polydipsia (3/25;12%), fever (2/25;8%), and abdominal distension 161 
(1/25;4%).  162 
 163 
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There were clinicopathological abnormalities in all 25 dogs.  Neutrophilia (12/25; 48%) was the 164 
most common hematological abnormality. Biochemical abnormalities were present in every dog, 165 
with elevated alkaline phosphatase (ALP) activity (22/25; 88%) the most common (Tables 1). 166 
 167 
Aerobic and anaerobic culture of bile was performed in 21/25 (84%) cases. Culture was positive 168 
in 1/21 dogs, yielding Escherichia coli in a dog with “CMHC moderate” and clinical findings of 169 
vomiting, neutrophilia with left shift, thrombocytosis, and elevated ALP. Review of medical 170 
records revealed that all dogs received perioperative antibiotics: cefazolin (four of 25; 16%), 171 
cefoxitin (15 of 25; 60%), and ampicillin-sulbactam (six of 25; 24%). The dog with E.coli 172 
detected from bile culture was receiving cefoxitin.  173 
 174 
Perioperative death occurred in three of 25 (12%) cases. Necropsies were not performed. Clinical 175 
signs in these dogs included vomiting alone in one dog, inappetence alone in one dog, and 176 
jaundice, vomiting, diarrhoea, lethargy and inappetence in the third dog. One dog had a 177 
neutrophilia and another had band neutrophilia with a normal neutrophil count. Two of three 178 
dogs were hyperbilirubinemic and hypoalbuminemic. Two of three dogs that died in the peri-179 
operative period had cholecystitis and were FISH+ but the cause of death was not determined. 180 
The remaining dog suffered respiratory arrest postoperatively and pulmonary thromboembolism 181 
was suspected, but not confirmed.  182 
 183 
FISH analysis of GB mucosa  184 
Bacteria that hybridized to the eubacterial FISH probe were detected in eight of 25 (32%) cases. 185 
Bacteria were noted adherent to the GB epithelium and/or invasive within the GB mucosa in all 186 
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dogs, some dogs also had bacteria visualized within the mucus. Three dogs had less than 10 187 
bacteria visualized; the remainder of the dogs had bacteria visualized as dense clusters or masses 188 
(Table 2; Figure 1). FISH analysis of the dog with E.coli cultured in the bile revealed masses of 189 
bacteria within luminal mucus and adhering to the GB wall (Figure 1, D).  190 
 191 
Sonographic Findings  192 
The sonographic appearance of the GB was consistent with mucocele (Besso et al. 2000) in 24 of 193 
25 (96%) cases. The dog lacking sonographic features of GBM was presented for vomiting and 194 
sonography revealed a thickened GB wall with peritoneal effusion so abdominal exploratory was 195 
performed. Seven of 25 (28%) dogs had an abnormal GB wall (hyperechoic [four/25; 16%], 196 
thickened [three of 25;12%], edema[four of 25;16%]). Nine of 25 (36%) had peritoneal effusion 197 
detected on abdominal ultrasound. One of these dogs had a moderate amount of effusion found 198 
diffusely throughout the abdomen; the other eight dogs had trace effusion reported. GB rupture 199 
was suspected based on the original ultrasound in two cases. Ultrasound correctly identified GB 200 
rupture in one of the two cases.  The dog that was incorrectly suspected of rupture presented for 201 
lethargy and hyporexia. This dog had hyperbilirubinemia, marked elevations in ALP and ALT, 202 
neutrophilia and band neutrophilia, and sonographic evidence of GBM with a thickened, 203 
hyperechoic, and oedematous GB wall, and a moderate peritoneal effusion (fluid cytology not 204 
performed). Surgical exploration found an intact GB. Histopathological diagnosis was CMHC 205 
(moderate), and no bacteria were evident on culture or FISH.  206 
 207 
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In five of 25 (20%) dogs, cholecystitis was listed as suspected in the ultrasound report based on 208 
abdominal ultrasound findings of GB wall abnormality, peritoneal effusion, and/or cystic bile 209 
duct. All five of those dogs had histopathological evidence of cholecystitis. .  210 
 211 
Histopathological Findings 212 
The original and blinded (23 of 25 cases) histopathological examinations indicated a diagnosis of 213 
CMH in all cases. The blinded examination documented CMH alone in eight of 25(32%) cases 214 
and CMH with concurrent cholecystitis (CMHC) in 17 of 25(68%). Cholecystitis was classified 215 
as mild in eight of 17(47%), moderate in seven of 17(41%), and  severe in two of 17(12%) 216 
(Figures 2 and 3). In three cases, necrosis of the GB wall was also noted along with cholecystitis 217 
(two moderate, one severe). Seven of eight (88%) FISH+ dogs had CMH with concurrent 218 
cholecystitis; one dog had CMH alone. Cholecystitis was classified as mild in three FISH+ dogs, 219 
as moderate in two FISH+ dogs, and as severe in two FISH+ dogs (Table 1). Rupture of the GB 220 
was not apparent histologically in any of the cases. However, rupture of the GB was documented 221 
at surgery in two of 25(8%) dogs, both with CMHC.  222 
 223 
Discussion  224 
 225 
In this study we evaluated the utility of FISH to demonstrate bacteria in the gallbladder of a 226 
group of dogs with GBM. In these dogs, FISH was more sensitive for the detection of bacteria 227 
(eight of 25; 32%) than aerobic and anaerobic culture, which was positive in only one of 21 228 
cases.   229 
 230 
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The importance of the bacteria identified in GBM by FISH is unclear. The accepted standard for 231 
diagnosis of bacterial infection in the biliary system is aerobic and anaerobic culture and 232 
sensitivity (Neer 1992). Further, this would ideally be correlated with cytologic results in order 233 
to attempt to determine whether the bacteria may be transient, iatrogenic contamination, or true 234 
biliary infection as healthy dogs have been shown to periodically harbor bacteria in the bile with 235 
no obvious clinical relevance (Kook et al. 2010). In humans with cholelithiasis and/or chronic 236 
cholecystitis there is also a wide variation in the reported rates of bacterial infection (0 to 73%) 237 
and controversy over the significance of the results (Lemos et al. 2010). FISH alone is unable to 238 
definitively prove infection versus transient bacteria versus iatrogenic contamination. However, 239 
in all of our cases bacteria were visualized adjacent to the GB wall or within the GB 240 
parenchyma, which would suggest pathogenic behaviour of the bacteria.  241 
 242 
In attempting to determine the significance of the bacteria seen by FISH, it is important to 243 
consider possible reasons for the discordancy between FISH and bacterial culture results. All 244 
dogs in the study were administered perioperative antibiotics, but it is unclear whether antibiotic 245 
administration would have influenced culture results. In a report of dogs undergoing cystotomy 246 
for urolithiasis the use of perioperative antibiotics did not change culture results when compared 247 
to antimicrobial administration following surgery (Buote et al. 2012). However, the dogs in our 248 
study did not all receive the same antibiotic and there may be a differential effect of 249 
antimicrobials on recovery of cultured bacteria. Additionally, it is possible some of the bacteria 250 
seen with FISH were not cultivable with routine culture methodologies. Also, the varied method 251 
of collection of GB contents/bile may affect the ability to consistently identify bacteria. During 252 
the time period of this study, our hospital generally submitted microbiology swabs of GB 253 
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contents following cholecystectomy for aerobic and anaerobic bacterial culture. Although there 254 
is no concrete evidence to suggest that swabs placed in transport media is inferior to a direct 255 
culture of bile or culture of GB tissue, it is possible this could have contributed to the 256 
discrepancy between bacterial culture results and the positive identification of bacteria using 257 
FISH in this group of dogs.  258 
 259 
Generally, identification of concurrent bacterial infection of the bile, GB mucosa or liver in cases 260 
of GBM is challenging. Ultrasound-guided percutaneous cholecystocentesis is a common and 261 
typically safe procedure for the collection of bile for the purposes of cytologic evaluation and 262 
culture (Uno et al. 2009, Peters et al. 2016, Schiborra et al. 2017). However, biliary mucocele is 263 
considered by many to be a contraindication to cholecystocentesis as the potential for GB 264 
necrosis secondary to GBM makes rupture of the biliary tract possible (Kook et al. 2010). A 265 
recent publication described 201 dogs that had percutaneous cholecystocentesis performed, six of 266 
which had GBM. Two of these dogs had complications from cholecystocentesis, one of which 267 
died from bile peritonitis (Schiborra et al. 2017). Aspirate of a GBM for collection of bile 268 
preoperatively is generally discouraged. Based on the results of this study, FISH could be 269 
considered as a complimentary diagnostic tool as it may be more sensitive than bacterial culture 270 
of bile in some instances, and has the added benefit of demonstrating the organism within the 271 
tissue. If a high suspicion of bacterial infection exists and bacterial culture is negative, FISH 272 
could be performed and while awaiting results an appropriate empirical antimicrobial could be 273 
administered to the dog. While FISH is unable to give information on antimicrobial 274 
susceptibility, the use of specialized probes may enable the identification of the bacterial species 275 
to help ensure appropriate choice of antimicrobial in regards to spectrum and penetration of 276 
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tissue. It remains unclear whether the bacteria seen are pathogenic and potentially contributing to 277 
the aetiopathogenesis or progression of GBM, or whether they are transient or of little clinical 278 
relevance. However, the number of GBM cases with bacteria visualized by FISH is of interest. 279 
Prospective studies utilizing bacterial culture, cytology, and FISH are needed to further evaluate 280 
the relationship between GBM and bacteria.  281 
 282 
In our cohort of 25 dogs with GBM, we found that only 32% had histological findings restricted 283 
to CMH. Concurrent cholecystitis was a common (17 of 25; 68%) co-morbidity and ranged from 284 
mild in seven of 17 (41%) to moderate-severe in nine of 17 (53%) cases. This is higher than 285 
previous reports of concurrent cholecystitis in 17 to 40% of dogs with GBM  (Besso et al. 2000, 286 
Pike et al. 2004, Worley et al. 2004, Malek et al. 2013). In theory, cholecystitis in GBM may be 287 
a consequence of inadequate GB emptying and subsequent ischemic or pressure necrosis of the 288 
GB wall. However, only three of 17 dogs with CMHC in the present study had evidence of GB 289 
wall necrosis. This suggests that factors other than wall necrosis, including bile stasis, infarction 290 
or bacterial infection (ascending or enterohepatic) may be involved (Aguirre 2010).  We found 291 
that clinical signs and clinicopathological findings were broadly similar in dogs with CMH and 292 
CMHC; however a higher percentage of dogs with CMHC were hyperbilirubinemic versus dogs 293 
with CMH alone. Thus the presence of hyperbilirubinemia may alert the clinician to the presence 294 
of cholecystitis in an otherwise benign appearing GBM. Furthermore, chronic cholecystitis is a 295 
condition that can result in pain, anorexia, vomiting, and weight loss, and the diagnosis may not 296 
always be obvious, especially in patients with other concurrent hepatobiliary disease (Aguirre 297 
2010). Thus, the high proportion of cholecystitis among the dogs in our study is noteworthy, and 298 
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may support the recommendation for early cholecystectomy, even in dogs with an otherwise 299 
benign-appearing mucocele.   300 
 301 
In our study, three of 25(12%) dogs died in the perioperative period following cholecystectomy. 302 
Definitive cause of death was not identified in any case. Two (67%) of these dogs had 303 
cholecystitis and were FISH+. The other dog had histopathological evidence of CMH alone and 304 
was FISH-. None of these dogs had GB rupture noted surgically or histopathologically.  The 305 
reason for perioperative death following cholecystectomy for treatment of GBM is not well 306 
understood. Although concurrent bacterial infection has not been correlated with perioperative 307 
mortality (Besso et al. 2000, Pike et al. 2004, Worley et al. 2004, Aguirre et al. 2007, Crews et 308 
al. 2009, Uno et al. 2009, Malek et al. 2013), the rate of bacterial infection has been variably 309 
described (Pike et al. 2004, Worley et al. 2004, Aguirre et al. 2007, Crews et al. 2009, Uno et al. 310 
2009, Malek et al. 2013, Mitzutani et al. 2017), which may limit the ability to make this 311 
correlation. In our two cases of perioperative death with cholecystitis and bacteria detected by 312 
FISH, death due to complications of cholecystitis (such as hemodynamic instability)  (Amsellem 313 
et al. 2006, Papazoglou et al. 2008) and/or translocation of bacteria from the biliary system and 314 
resulting septicemia could be considered as possible causes.  315 
 316 
The limitations of FISH should be considered. A negative FISH result does not exclude the 317 
presence of bacteria. Despite enzyme degradation steps, inherent differences in the permeability 318 
of different bacteria to FISH probes may lead to a failure to detect some gram positive and acid 319 
fast bacteria.  The eubacterial FISH probe employed in this study will only detect viable bacteria 320 
with intact 16S, it will not recognize dead bacteria. It is important to note the inherent difficulties 321 
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of studies that utilize subjective histopathology. The use of standardized scoring schemes are 322 
typically employed to reduce subjectivity. However, despite this there is still poor agreement 323 
among histopathologists in studies describing hepatic and intestinal lesions in dogs (Jergens et al. 324 
2014, Lidbury et al. 2017). Finally, the retrospective nature of this study made it difficult to 325 
accurately determine the incidence of concurrent diseases previously reported to be associated 326 
with GBM (e.g. endocrine disease, hyperlipidemia) (Mesich et al. 2009, Kutsani et al. 2014, 327 
Gookin et al. 2015) and postsurgical outcomes.  328 
 329 
In conclusion, FISH detected bacteria in eight of 25 (32%) dogs with GBM and was more 330 
sensitive for the detection of bacteria than bacterial culture. Additional investigation is needed to 331 
further determine the relationship between bacteria and GBM and its relation to 332 
aetiopathogenesis or progression of disease, clinicopathologic abnormalities, ultrasound findings, 333 
histopathological findings, and outcome. The high proportion of occult cholecystitis may support 334 
the recommendation for early elective cholecystectomy in dogs with GBM. Additional 335 
investigation is also needed to further elucidate the relationship between GBM and cholecystitis.  336 
 337 
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Table 1. Selected clinical, clinicopathologic, sonographic and histopathologic abnormalities in 486 
dogs with gallbladder mucocele that were FISH- versus FISH+ 487 
 488 
Variable Reference Interval 
 
FISH+ 
n=8 
Median (range) 
Proportion 
FISH- 
n=17 
Median (range) 
Proportion 
Clinical signs 
_ 
 
7/8 (88%) 
 
11/17 (65%) 
Neutrophilia 2.6-11 (x10⌃ 3/ul) 
10.8 (2.3-22.6) 
3/8 (38%) 
12.5 (4.5-20) 
9/17 (53%) 
Increased band 
neutrophils 0-0.2 (x10⌃ 3/ul) 
0.3 (0-1.7) 
4/8 (50%) 
0 (0-0.4) 
1/17 (6%) 
Thrombocytosis 200-500 (x10⌃ 3/ul) 
405 (167-664) 
2/8 (25%) 
358 (188-735) 
3/17 (18%) 
Hypoalbuminemia 3-4.3 (G/dl) 
3.3 (1.8-4) 
3/8 (38%) 
3.5 (2.4-4.1) 
1/17 (6%) 
Hyperbilirubinemia 0-0.2 (mG/dL) 
1.4 (0.1-13.9) 
5/8 (63%) 
0.2 (0-4.5) 
5/17 (29%) 
Elevated ALP 15-140 (IU/L) 
1554 (62-5579) 
7/8 (88%) 
786 (69-9718) 
15/17 (88%) 
Elevated ALT 10-90 (IU/L) 
472 (23-2776) 
6/8 (75%) 
162 (26-1477) 
13/17 (76%) 
Sonography: 
Peritoneal effusion 
_ 
 
2/8 (25%) 
 
7/17 (41%) 
Sonography:  
GB wall abnormality 
_  
4/8 (50%) 
 
3/17 (18%) 
CMH 
_ 
 
1/8 (13%) 
 
7/17 (41%) 
CMHC all  
_  
7/8 (88%) 
 
10/17 (59%) 
CMHC mild  
_  
3/8 (38%) 
 
5/17 (29%) 
CMHC moderate 
_ 
 
2/8 (25%) 
 
4/17 (29%) 
CMHC severe  _ 2/8 (25%) 1/17(6%) 
 489 
GB wall abnormality includes: hyperechogenicity, increased wall thickness, oedema, or 490 
discontinuous wall consistent with rupture. GB=gallbladder; CMH=cystic mucinous hyperplasia 491 
alone; CMHC=cystic mucinous hyperplasia + cholecystitis.  492 
 20 
Table 2. Number and location of bacteria in FISH+ dogs with GBM.  493 
 494 
X symbols denote the dogs listed (dogs 1-8; y-axis) had the characteristics in the x-axis (<10 495 
bacteria, etc) in their individual tissue sample  496 
 497 
 498 
 499 
 500 
 501 
 502 
 503 
 504 
 505 
 506 
 507 
 508 
 509 
 510 
 511 
 512 
 513 
 514 
 515 
 516 
 517 
 518 
Dog <10 bacteria ≥10 bacteria Adherent Invasive 
Within 
Mucus 
1 X   X  
2  X X X  
3  X X  X 
4 X  X   
5  X  X X 
6  X X  X 
7  X X  X 
8 X   X X 
 21 
 519 
Figure 1. FISH analysis of gall bladder mucocele. 520 
 (A) FISH of GMB and CMH with Cy3-EUB-338 (red) 6-FAM-Non-EUB-338 (green) reveals a 521 
smooth villus lining with no bacteria visualized (B) FISH of GBM CMHC (moderate) with Cy3-522 
EUB-338 (red) and 6-FAM-Non-EUB-338 (green) reveals the presence of four bacteria (red) 523 
within the gallbladder epithelium (insert) (C) GBM CMHC (severe) with clusters of bacteria 524 
(red) within intraluminal debris and the gallbladder epithelium (insert) (D) GBM CMHC 525 
(moderate) with masses of bacteria (red) within the gallbladder mucus and adjacent to the 526 
gallbladder wall (insert). DAPI (4′,6′-diamidino-2-phenylindole) stained nuclei are blue 527 
 528 
 529 
 530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
 538 
 539 
 540 
 541 
 542 
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 543 
 544 
Figure 2. Histopathological characteristics in 25 dogs with GBM. GBM gallbladder mucocele, 545 
CMH cystic mucinous hyperplasia alone, CMHC cystic mucinous hyperplasia with cholecystitis 546 
 547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
GBM
n=28
CMH
n=8
CMHC
n=17
mild 
n=8
moderate
n=7
severe 
n=2
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 562 
Figure 3. Photomicrograph of gallbladder biopsy sections of dogs with gallbladder mucocele. 563 
Hematoxylin-eosin stained section showing (A) no significant cellular infiltrates within the 564 
gallbladder epithelium with thin villus projections (arrow) into luminal mucus (CMH) (B) mild 565 
cellular infiltrates within the gallbladder epithelium with thickened, more cellular villus 566 
projections (arrow) into luminal mucus (CMHC-mild) (C) moderate cellular infiltrates within the 567 
gallbladder epithelium with thicker and loculated villus projections (arrow) into luminal mucus 568 
(CMHC-moderate) (D) marked cellular infiltrate with areas of necrosis within the gallbladder 569 
epithelium with blunting, thickening, and cellular infiltration of the villus projections (arrow) 570 
into the luminal mucus (CMHC-severe) 571 
 572 
 573 
 574 
